Skip to content

„Aktiv gegen Erschöpfung und Stress“ - Evaluation of a 2-week prevention programme including a refresher, carried out in health resort Bad Birnbach

„Aktiv gegen Erschöpfung und Stress“ - Evaluation of a 2-week prevention programme including a refresher, carried out in health resort Bad Birnbach - AGES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011290
Enrollment
82
Registered
2016-11-15
Start date
2015-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People having a high stress load and therefore being at risk to develop a stress-related health problem (burnout-syndrome) Z73

Interventions

Group 1: Participants of the intervention group (group A) travel to Bad Birnbach and take part at the 2-week preven-tion programme including the psycho-educational teaching. Six months later, they joi

Sponsors

Lehrstuhl für Public Health und Versorgungsforschung (IBE)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: - People with increased stress load - TICS-SSCS: = Mean (T-value: 50; Score 13) = Mean + 3.5 SD (T-Wert: 72; Score 38) (see manual Schulz, Schlotz & Becker) - Informed consent was given

Exclusion criteria

Exclusion criteria: - Being in need for treatment of burnout-syndrome (MBI scale: > 5.0, as stated by Prof. Dr. Jürgen Glaser, Work and Organizational Psychology, University of Innsbruck) - acute illness

Design outcomes

Primary

MeasureTime frame
Current subjectively perceived stress assessed using the Perceived Stress Questionnaire (PSQ) at: Baseline (T0 - pre intervention), 1-month (T2), 3-month (T3), 6-month (T4) and 12-month follow-up (T5), respectively; Chronic stress assessed by the means of the Trierer Inventory for chronic stress (TICS) at: Baseline (T0 - pre intervention), 3-month (T3), 6-month (T4) and 12-month follow-up (T5), respectively;

Secondary

MeasureTime frame
- Cortisol concentration in saliva (cortisol awakening response, CAR) at: baseline and at post 2-week intervention phase (T1) and pre/post 4-days intervention phase (T4); - Quality of sleep Pittsburgh Sleep Quality Index (PSQI) at: T0, T2, T3, T4, T5 - Health-related quality of life/subjective health status (EuroQol-5D) at: T0, T1, T2, T3, T4, T5 - Current well-being using the WHO-5 Well-Being-Index (WHO-5) at: T0, T1, T2, T3, T4, T5 - Health-related behaviour at: T0, T2, T3, T4, T5 - Evaluation of satisfaction with the programme (group A and B only) at: T1 (post 2-week intervention) and T4 (post 4-days intervention (refresher));

Countries

Germany

Contacts

Public ContactSandra Kus

Lehrstuhl für Public Health und Versorgungsforschung (IBE)

skus@ibe.med.uni-muenchen.de089 2180-78228

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026